Immunotherapy can now be considered a viable modality for treatment of head and neck cancers
Practice Focus » Head and Neck
The American Cancer Society (ACS) has issued a new guideline that addresses the long-term needs of survivors of head and neck cancer.
Individual frozen section reads are highly accurate, but negative intraoperative margins do not guarantee margin-negative resection
New immunotherapy improves overall survival and improves quality of life with fewer side effects in a treatment-resistant and rapidly progressing form of head and neck carcinoma, reports a large, randomized international trial.
High complication rates and a lack of proven best approaches suggest tailoring the approach to address the potential risks based on location and severity
TGDC cancer diagnosis compris- es a heterogeneous group that includes true TGDC cancer, pyramidal lobe primary, Delphian node metastasis, and indeterminate case